Loading the security page…
A security analysis is not yet prepared for this market.
Based on reports through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Atrium Therapeutics, Inc. (RNA) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Atrium Therapeutics, Inc. (RNA) on November 10, 2026 is 8.19 $, −2.27 % on the day. Over 52 weeks the stock traded between 7.49 $ and 16.77 $; the price now sits 8 % of the way up that range. Market capitalization is 142.49 million $, rank 215 among 380 stocks of the same industry with a known capitalization.
Atrium Therapeutics, Inc. trades on Nasdaq under the ticker RNA. The company belongs to the Health care sector. The trading history on this page starts on 27 February 2026.
Over the past 52 weeks RNA has traded between 7.49 $ and 16.77 $. As of 10 November 2026 the price stood 11.42% of the way from the 52-week low to the high.
Price to book is 0.7, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.